![434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer 434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A94.3/F1.large.jpg)
434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer
![Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09510-7/MediaObjects/12885_2022_9510_Fig3_HTML.png)
Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text
![Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825822001433-ga1.jpg)
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect
![Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f4a630b6-11bd-4fd6-ae8e-0cae8dc6ef7f/ijc33907-toc-0001-m.png)
Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library
![Cancers | Free Full-Text | Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer Cancers | Free Full-Text | Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer](https://www.mdpi.com/cancers/cancers-13-01367/article_deploy/html/images/cancers-13-01367-g001.png)
Cancers | Free Full-Text | Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
![Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825822001433-gr1.jpg)
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect
![NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months](https://pbs.twimg.com/media/FJf6WueVIAMWHvU.jpg)
NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
![Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series - ScienceDirect Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419345326-gr1.jpg)
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series - ScienceDirect
![Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population](https://www.frontiersin.org/files/Articles/699577/fonc-11-699577-HTML/image_m/fonc-11-699577-g001.jpg)
Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population
![Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/32/9/1129/F2.large.jpg)
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer
![Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy? Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?](https://pub.mdpi-res.com/cancers/cancers-14-00912/article_deploy/html/images/cancers-14-00912-g001.png?1645068354)
Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
![Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis | BMC Cancer | Full Text Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-10482-x/MediaObjects/12885_2022_10482_Fig4_HTML.png)